NEW YORK (GenomeWeb News) - Enzo Biochem today said that a federal court issued a ruling supporting the company's claims that "hundreds" of products marketed by certain companies infringe eight of Enzo's patents.
The ruling allows Enzo to pursue patent-infringement claims against Affymetrix, Roche, Amersham, PerkinElmer, Sigma Aldrich, Orchid Biosciences and Molecular Probes. It also enables Enzo to claim that the defendants breached their contractual obligations to Enzo.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.
An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.
The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.
For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.